We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Neurocrine (NBIX) Biosciences announced top-line data from a Phase 4 study, KINECT-PRO, demonstrating clinically meaningful and sustained effects of INGREZZA capsules on the physical, social and ...
TL;DR: If you're looking for a powerful productivity suite without recurring subscription fees, Microsoft Office 2021 is available for just $54 for a limited time – an incredible deal and one of ...
JPMorgan lowered the firm’s price target on Neurocrine (NBIX) to $183 from $191 and keeps an Overweight rating on the shares. The firm updated the company’s model to include Ingrezza revenue ...
Starbucks is cutting 1,100 corporate positions as part of a bid to create “smaller, more nimble teams,” CEO Brian Niccol wrote in a message to employees Monday. It’s one of the largest ...
Saks has decided to close Neiman Marcus’ Dallas headquarters office in a cost-saving move, the Dallas Morning News reported. It wasn’t unexpected after privately-owned HBC closed the $2.7 ...
A growing cohort of biotechs, from Biohaven to Neurocrine to Jazz, hope research on ion channels will bring them new drugs and big business — much like it has done for Vertex.
SAN DIEGO, Feb. 21, 2025 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that its Board of Directors has authorized a new share repurchase program under which Neurocrine ...
SAN DIEGO, Feb. 21, 2025 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that its Board of Directors has authorized a new share repurchase program under which ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results